Cargando…
Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy
The development of DNA microarray technologies over the past decade has revolutionised translational cancer research. These technologies were originally hailed as more objective, comprehensive replacements for traditional histopathological cancer classification systems, based on microscopic morpholo...
Autores principales: | Vitucci, M, Hayes, D N, Miller, C R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049580/ https://www.ncbi.nlm.nih.gov/pubmed/21119666 http://dx.doi.org/10.1038/sj.bjc.6606031 |
Ejemplares similares
-
'Chumanzee' evolution: the urge to diverge and merge
por: Disotell, Todd R
Publicado: (2006) -
Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside
por: Boisguérin, V, et al.
Publicado: (2014) -
The genetics of gout: towards personalised medicine?
por: Dalbeth, Nicola, et al.
Publicado: (2017) -
Merging Plastics, Microbes, and Enzymes: Highlights from an International Workshop
por: Jiménez, Diego Javier, et al.
Publicado: (2022) -
Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
por: Hunter, Francis W, et al.
Publicado: (2016)